The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Its a trend that has no precedence, covid is a new thing. 400p by friday, more if there is further news
Haha atleast give it a week to settle in. Week will be a blue week, great rns regardless
Well said.
Thumbs up
The demand for the kits is huge, once the supply is increased so will revenue... massively.
Matt whilst you focus on the estimates vs actuals, thats all they are estimates. Fact of the matter is they are still a significant increase on previous periods and the upward trend for the sales still continues. The issue is not demand for the kits as covid is real, the issue is manufacturing. With revenues being generated it is a matter of time before the manufacturing process steps up, either by means of JV or by increasing facilities. Either way we are making a profit, in an industry that is highly highly needed, creating a product to aid the globe wide pandemic.... ITS UP FROM HERE AND WILL BE FOR A WHILE. expect talks of divi, jv, ipo etc. Keyword TRANSFORMATIONAL. NO RAMPING - 100% BASED ON NEWS
Debt Free - for the first time in companies history.
News drop before Friday. What it is i do not know, could be agreement to supply kits, partner agreements to support supply, IPO.... anyones guess. 6 months ago nobody could have guessed NOV would be here .
Absolutely! Positive weeks, months, year ahead. Keyword =`Transformational'
Due to the US footprint this one will see some more blue once US markets open and other overseas markets.
Correct. Valuations will only get higher as the need becomes greater
As good as £22.50 sounds, id be happy with £10 over next 3 months.
over 900% to €72.4 million (£63.3 million), compared to revenue of €7.2 million (£6.3 million) for the first half of 2019, with 91% of revenue accounted for in the second quarter. For the half year, the Group estimates EBITDA profitability over €45 million (£41 million). This follows the successful launch of one of the world’s first molecular tests for COVID-19, which the Company rapidly developed and launched in January 2020.
The Company’s cash position as at 30 June 2020 was €20 million (£18 million) (cash as at 31 December 2019 of €1.8 million (£1.6 million)). This strong cash position is after significant investment to meet continued demand for the COVID-19 test expected in the second half of the year. It is also reported after paying down all outstanding debt, making Novacyt debt free for the first time in the Company’s history.
More news
https://www.investorschronicle.co.uk/shares/2020/07/13/novacyt-transforms/
Press are on this.
https://www.morningstar.co.uk/uk/news/AN_1594624050440472300/london-briefing-novacyt-sales-multiply-amid-demand-covid-19-test.aspx
Jonny jonny jonny, what took you to 500p was a fraction of the news of what has been delivered today. This is far better, far bolder, far sexier and will attract a good latter trading day. Early morning sells were the sheep that usually get scared in morning but the buys are rolling in, be positive. Study the law of attraction, expect 400p, attract 400p, get 400p. Try it jonny, you wont regret it.
Wheres the fun in staying at current levels when you have a rns like this, when was the last time you remember someone on aim positing 900% increase in revenue and that from a debt free company???? One off opportunity thanks to covid. It will 100% finish above 300p that is easy, im saying based on my understanding of this share and the interest it generates topped with the news that this will easily reach 400p
And jonny quotes are getting higher so price is actually rising mate, sell your ego and buy live
Jonny give it a rest with your deramping. The news is news, and your posts are just clearly a result of your poor judgement, lesson learnt... never short covid stocks during covid lol. This will go to 400p and beyond whether you like it. I believe the rns over jonny bravo condorm
Let he Americans wake up